What is Shenzhenlubris Pharmaceuticals Co Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. Shenzhenlubris Pharmaceuticals Co's pretax income for the
three
months ended in Mar. 2025 was ¥228 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥630 Mil.
Shenzhenlubris Pharmaceuticals Co's pretax margin was 21.46%.
During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest Pretax Margin was 43.05%. The lowest was 2.07%. And the median was 20.06%.
Shenzhenlubris Pharmaceuticals Co Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shenzhenlubris Pharmaceuticals Co Pre-Tax Income Chart
Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income
For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥630 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Pre-Tax Income Explanation
Shenzhenlubris Pharmaceuticals Co's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as
During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest Pretax Margin was 43.05%. The lowest was 2.07%. And the median was 20.06%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhenlubris Pharmaceuticals Co Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Shenzhenlubris Pharmaceuticals Co Business Description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002294 has been successfully added to your 